EGF and cancer: In this regard, VEGF isoforms and their tyrosinekinase receptors VEGFRs, as well as epidermal growth factor (EGF) and itsreceptor (EGFR) are currently explored in clinical trials as drug candidatesagainst cancer [43–45].